Foundations for a Personalized Psycho-Oncology: The State of the Art.

cancer-related psychological distress drug–drug interactions inflammatory biomarkers personalized follow-up personalized medicine psychiatric disorders psycho-oncology psychological disorders psychotherapeutic interventions tailored mental health care

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
23 Aug 2024
Historique:
received: 29 05 2024
revised: 09 08 2024
accepted: 21 08 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Personalized psycho-oncology represents a major challenge for the holistic care of cancer patients. It focuses on individualized psychotherapeutic and psychiatric interventions to address specific psychological needs. This narrative review summarizes the current literature on personalized psycho-oncology and highlights the prevalence and impact of psychiatric/psychological disorders in cancer patients. Personalized approaches, including tailored interventions and interdisciplinary collaboration, have been shown to be effective in improving mental health and overall quality of life. The integration of inflammatory biomarkers into treatment plans is a promising but challenging way to alleviate mental health problems. In addition, there is a need for specific diagnostic tools and treatment guidelines that take into account the specific psychological impact of different types of cancer. Future research should aim to refine these personalized strategies, improve diagnostic accuracy, and evaluate the cost-effectiveness of these interventions to improve both the psychological well-being and treatment outcomes of cancer patients.

Identifiants

pubmed: 39338146
pii: jpm14090892
doi: 10.3390/jpm14090892
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Giampaolo Perna (G)

Department of Biological Sciences, Humanitas University, 20089 Milan, Italy.
IRCCS Humanitas Research Hospital, 20089 Milan, Italy.

Eleonora Pinto (E)

Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.

Alessandro Spiti (A)

IRCCS Humanitas Research Hospital, 20089 Milan, Italy.

Tatiana Torti (T)

ASIPSE School of Cognitive-Behavioral-Therapy, 20124 Milan, Italy.

Michele Cucchi (M)

IRCCS Humanitas Research Hospital, 20089 Milan, Italy.

Daniela Caldirola (D)

Department of Biological Sciences, Humanitas University, 20089 Milan, Italy.

Classifications MeSH